REVELATION BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable
REVELATION BIOSCIENCES, INC. (REVB) reported Increase (Decrease) in Accounts Payable of $353.59 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $136.69K, a 32.94% decline year-over-year.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $216.90K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$442.45K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $191.06K, a 89.65% decline year-over-year.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was -$206.12K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was -$576.28K, a 176.87% decline from fiscal 2023.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was $749.66K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was -$666.04K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $136.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $353.59K 10-Q · filed 2026-08-06 | -$88.86K derived: sum of 3 quarters · filed 2026-08-06 | $102.20K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $216.90K 10-Q · filed 2026-05-07 | -$225.55K derived: sum of 2 quarters · filed 2026-05-07 | -$34.49K derived: sum of 3 quarters · filed 2026-05-07 | $169.34K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$442.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$251.39K derived: sum of 2 quarters · filed 2026-02-26 | -$47.56K derived: sum of 3 quarters · filed 2026-08-06 | -$206.12K 10-K · filed 2026-02-26 |
| 2025-09-30 | $191.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $394.89K derived: sum of 2 quarters · filed 2026-08-06 | $236.33K 10-Q · filed 2025-11-06 | -$2.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $203.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $45.27K 10-Q · filed 2026-08-06 | -$2.30M derived: sum of 3 quarters · filed 2026-08-06 | -$452.43K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$158.56K 10-Q · filed 2026-05-07 | -$2.50M derived: sum of 2 quarters · filed 2026-05-07 | -$656.26K derived: sum of 3 quarters · filed 2026-05-07 | -$1.06M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$497.70K derived: sum of 2 quarters · filed 2026-02-26 | -$898.04K derived: sum of 3 quarters · filed 2026-02-26 | -$576.28K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.45M derived: sum of 2 quarters · filed 2025-11-06 | $1.77M 10-Q · filed 2025-11-06 | $1.80M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$400.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$78.58K 10-Q · filed 2025-08-08 | -$49.85K derived: sum of 3 quarters · filed 2025-08-08 | $293.51K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $321.77K 10-Q · filed 2025-05-08 | $350.49K derived: sum of 2 quarters · filed 2025-05-08 | $693.85K derived: sum of 3 quarters · filed 2025-05-08 | $902.63K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $28.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $372.08K derived: sum of 2 quarters · filed 2025-03-06 | $580.86K derived: sum of 3 quarters · filed 2025-03-06 | $749.66K 10-K · filed 2025-03-06 |
| 2023-09-30 | $343.36K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-08 | $552.13K derived: sum of 2 quarters · filed 2024-11-08 | $720.94K 10-Q · filed 2024-11-08 | $791.14K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $208.78K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-09-23 | $377.58K 10-Q/A · filed 2024-09-23 | $447.78K derived: sum of 3 quarters · filed 2024-09-23 | -$2.61K derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | $168.80K 10-Q/A · filed 2024-09-23 | $239.00K derived: sum of 2 quarters · filed 2024-09-23 | -$211.39K derived: sum of 3 quarters · filed 2024-09-23 | -$755.76K derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | $70.20K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | -$380.19K derived: sum of 2 quarters · filed 2024-09-23 | -$924.56K derived: sum of 3 quarters · filed 2024-09-23 | -$666.04K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | -$450.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$994.76K derived: sum of 2 quarters · filed 2023-11-09 | -$736.25K 10-Q · filed 2023-11-09 | -$1.17M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$544.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$285.86K 10-Q · filed 2023-08-11 | -$720.70K derived: sum of 3 quarters · filed 2023-08-11 | -$596.64K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $258.51K 10-Q · filed 2023-05-22 | -$176.32K derived: sum of 2 quarters · filed 2023-05-22 | -$52.27K derived: sum of 3 quarters · filed 2023-05-22 | -$229.88K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | -$434.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$310.79K derived: sum of 2 quarters · filed 2023-03-30 | -$488.39K derived: sum of 3 quarters · filed 2023-03-30 | -$269.64K 10-K · filed 2023-03-30 |
| 2021-09-30 | $124.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$53.55K derived: sum of 2 quarters · filed 2022-11-10 | $165.20K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$177.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $41.15K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $218.75K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |